radio active iodine refractory
Showing 1 - 25 of >10,000
Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )
Recruiting
- Differentiated Thyroid Cancer
- Dabrafenib
- +3 more
-
Caba, Buenos Aires, Argentina
- +41 more
Nov 25, 2022
Metastatic Thyroid Cancer Trial in Essen (Trametinib 2 MG [Mekinist], Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2)
Recruiting
- Metastatic Thyroid Cancer
- Trametinib 2 MG [Mekinist]
- Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2) [Tafinlar]
-
Essen, Northrhine-Westphalia, GermanyManuel M. Weber
May 17, 2022
Thyroid Cancer, Thyroid, Refractory Thyroid Cancer Trial in New York (Surveillance Visit)
Recruiting
- Thyroid Cancer
- +2 more
- Surveillance Visit
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 8, 2023
Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)
Active, not recruiting
- Multiple Myeloma
- Iodine I 131 Tositumomab
-
Ann Arbor, MichiganUniversity of Michigan
Mar 16, 2022
Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Oviedo, Asturias, Spain
- +9 more
Dec 14, 2022
Hyperhidrosis Primary Focal Axilla Trial in Warner Robins, Dallas (Morpheus8 Applicator (with the 24 pin tip) in the treatment
Active, not recruiting
- Hyperhidrosis Primary Focal Axilla
- Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis.
-
Warner Robins, Georgia
- +1 more
May 5, 2023
Thyroid Carcinoma
Recruiting
- Differentiated Thyroid Carcinoma
- Medullary Thyroid Carcinoma
- Immunohistochemistry (IHC)
- +2 more
-
L'Hospitalet De Llobregat, Barcelona, Spain
- +11 more
Mar 22, 2022
Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Lenvatinib Plus I-125 Seed Brachytherapy, Lenvatinib)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Lenvatinib Plus I-125 Seed Brachytherapy
- Lenvatinib
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Nov 2, 2022
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)
Not yet recruiting
- Non-Medullary Thyroid Carcinoma
- Digoxin tablet
- (no location specified)
Aug 20, 2022
Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)
Active, not recruiting
- Thyroid Carcinoma
- Vemurafenib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 28, 2022
High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)
Not yet recruiting
- High-Grade Glioma
- CLR 131
-
New York, New York
- +2 more
Nov 3, 2022
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022
Colorectal Tumors, Colorectal Cancer, Colorectal Tumor Trial in New York (Iodine-124 labeled humanized A33 (antibody))
Active, not recruiting
- Colorectal Neoplasms
- +3 more
- Iodine-124 labeled humanized A33 (antibody)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 26, 2022
Ventricular Arrythmia Trial in Warsaw (Ablation)
Recruiting
- Ventricular Arrythmia
- Ablation
-
Warsaw, PolandDepartment of Cardiology, Postgraduate Medical School, Grochowsk
Jan 21, 2023
Differentiated Thyroid Cancer Trial in Nanjing, Peking (Apatinib Oral Tablet, Placebo Oral Tablet)
Active, not recruiting
- Differentiated Thyroid Cancer
- Apatinib Oral Tablet
- Placebo Oral Tablet
-
Nanjing, Jiangsu, China
- +1 more
Aug 9, 2021
Differentiated Thyroid Cancer Trial in China (AL2846 capsule)
Recruiting
- Differentiated Thyroid Cancer
- AL2846 capsule
-
Guilin, Guangxi, China
- +3 more
Feb 27, 2023
Thyroid Cancer Trial in Ghent (PET/CT scan F18-PSMA-11)
Recruiting
- Thyroid Cancer
- PET/CT scan F18-PSMA-11
-
Ghent, BelgiumUniversity hospital Ghent
Feb 7, 2022
Thyroid Cancer Trial in United Kingdom (I131 1.1 GBq)
Active, not recruiting
- Thyroid Cancer
- I131 1.1 GBq
-
Birmingham, United Kingdom
- +31 more
Nov 4, 2020
Iodine Status of Indigenous Peoples (Karen) Living in Thailand
Recruiting
- Iodine Deficiency
-
Kanchanaburi, ThailandSanaephong, Kongmongta, and Koh Sadueng Villages
Jun 17, 2023
Comparison of I-FFQ and Two Reference Methods
Completed
- Iodine Deficiency
- spot urine samples
-
Bergen, NorwayUniversity of Bergen
Jul 3, 2023
Iodine Deficiency, Nutrition Poor, Development, Infant Trial (UNIMAP Multiple Micronutrient Supplement)
Not yet recruiting
- Iodine Deficiency
- +3 more
- UNIMAP Multiple Micronutrient Supplement
- (no location specified)
Jun 5, 2023
During Pregnancy and Mechanism of Breast Iodine Homeostasis
Not yet recruiting
- Nutritional Requirements
- dietary intervention
-
Lanzhou, China
- +1 more
Feb 15, 2023
Iodine Nutrition Status on Thyroid Function of Childbearing Age
Not yet recruiting
- Thyroid Function
- Iodine Nutrition Status
- iodine nutrition status
- (no location specified)
Jan 28, 2023